Eli Lilly (LLY) news
Recent news
ImportantAtaib Eckley - Hart-Scott-Rodino waiting period for merger with Eli Lilly expired on Aug 28, 2026 - SEC filing
AInvest Wire · 5d ago3M's Bill Brown, Eli Lilly's Ricks to attend G20: Politico
Business leaders from major corporations, including 3M’s Bill Brown and Eli Lilly’s David Ricks, are set to participate in the G20 finance meeting in Asheville, North Carolina. The two-day gathering brings together finance ministers, central bank governors, and private-sector executives from the…
AInvest Wire · 5d agoLilly: Data on Taltz, Zepbound show positive results in obesity
AInvest Wire · 5d agoEli Lilly: Adverse events in participants treated with Taltz and Zepbound together were generally mild to moderate
Recent clinical findings indicate that adverse events in participants treated with Eli Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) in combination were generally mild to moderate in severity. The data, derived from ongoing studies, suggest that the combined therapy was generally…
AInvest Wire · 5d agoEli Lilly - Taltz and Zepbound lead to deeper improvements in systemic inflammation in both trials
AInvest Wire · 5d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.